Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

FROG JFrog Ltd. Ordinary Shares
$60.03 3.41% +1.99
Notify me if price changes either direction
Interactive Brokers Logotype

Buy FROG stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 6.9B
Enterprise value 6.3B
Trailing PE -95.285714285714
Forward PE 66.0786
PEG Ratio 2.8585714285714
Enterprise to EBITDA -98.642
Enterprise to revenue 12.481
Price to book MRQ 8.043777
Price to sales TTM 13.754186

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 502.6M
EBITDA -63595000
Diluted EPS TTM -0.7
Total Cash (MRQ) 651.1M
Current ratio (MRQ) 2.177
Operating Cash Flow (TTM) 144.2M

FROG trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent FROG News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.